Phase 2 Non-Hodgkin Lymphoma Refractory/ Relapsed Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL
Non-Hodgkin Lymphoma Refractory/ Relapsed
King Hussein Cancer Center26 enrolled1 locationNCT07271121
Recruiting
Phase 2
Amping up With PemJAK
Non-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+2 more
Seda S. Tolu53 enrolled1 locationNCT07283822